Training the next generation of pluripotent stem cell researchers by unknown
BioMed CentralJournal of Translational Medicine
ssOpen AcceEditorial
Training the next generation of pluripotent stem cell researchers
Philip Hitchins Schwartz1,2
Address: 1Center for Translational Research, Children's Hospital of Orange County Research Institute, 455 South Main Street, Orange, California 
92868 USA and 2Center for Neuroscience Research, Children's Hospital of Orange County Research Institute, 455 South Main Street, Orange, 
California 92868 USA
Email: Philip Hitchins Schwartz - pschwartz@choc.org
Abstract
Human pluripotent stem cells (PSCs) have the unique properties of being able to proliferate
indefinitely in their undifferentiated state and of being able to differentiate into any somatic cell
type. These cells are thus posited to be extremely useful for furthering our understanding of both
normal and abnormal human development, providing a human cell preparation that can be used to
screen for new reagents or therapeutic agents, and generating large numbers of differentiated cells
that can be used for transplantation purposes. PSCs in culture have a specific morphology and they
express characteristic surface antigens and nuclear transcription factors; thus, PSC culture is very
specific and requires a core skill set for successful propagation of these unique cells. Specialized
PSC training courses have been extremely valuable in seeding the scientific community with
researchers that possess this skill set.
Human pluripotent stem cells (PSCs) have the unique
properties of being able to proliferate indefinitely in their
undifferentiated state and of being able to differentiate
into any somatic cell type. These cells are thus posited to
be extremely useful for furthering our understanding of
both normal and abnormal human development, provid-
ing a human cell preparation that can be used to screen for
new reagents or therapeutic agents, and generating large
numbers of differentiated cells that can be used for trans-
plantation purposes [1,2]. PSCs in culture have a specific
morphology and they express characteristic surface anti-
gens and nuclear transcription factors; thus, PSC culture is
very specific and requires a core skill set for successful
propagation of these unique cells. Specialized PSC train-
ing courses have been extremely valuable in seeding the
scientific community with researchers that possess this
skill set.
Most current lines of human PSCs have been obtained
from the inner cell mass of embryos produced by in vitro
fertilization. These embryo-derived PSCs (ePSCs, more
commonly known as ESCs or embryonic stem cells) are
currently the "gold standard" for PSCs. A new source of
PSCs has recently become available, however: somatic
cells that are re-programmed to PSCs – induced PSCs
(iPSCs). To generate iPSCs, somatic cells are genetically
transduced to express once-silent developmental genes
that re-program these cells into PSCs. Two recent publica-
tions have demonstrated the success of this technique
with human cells. In one case, the cells were transduced to
express the transcription factors Nanog, Oct4, Sox2, and
Lin28 [3]. In the other, c-Myc, Oct4, Sox2, and Klf4 were
required for the re-programming[4]. The iPSCs are of par-
ticular importance as they provide a potential source of
patient-specific cells for transplantation, i.e. immune-
matched cells, as well as the opportunity to study PSCs
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eases. As these cells do not have the ethical baggage asso-
ciated with ePSCs[5,6], they are likely to be accepted as
research tools all over the world.
As with all PSCs, a specific skill set is required for propa-
gation of iPSCs. Moreover, the transformation of a start-
ing pleiomorphic cell in the midst of a dense culture of
similar pleiomorphic cells to a very small colony of cells
resembling a PSC colony requires not only the appropri-
ate application of genetic reprogramming technology but
a trained eye to recognize the morphological progression
that the cells undergo. That is, additional skill sets are
required for iPSCs: 1) the appropriate lentiviral transduc-
tion techniques, using multiple vectors necessary for
reprogramming, 2) an ability to recognize the appearance
of the re-programmed cells amongst a large excess of non-
reprogrammed cells, and 3) an ability to "pick" colonies
of appropriately reprogrammed cells and then expand
them to derive the new iPSC line and characterize them to
prove that they are, in fact, PSCs. Bringing in ePSC biolo-
gists and training them in this new technology is but a first
step in advancing this field. Another step is to bring in and
train scientists outside the PSC field, such as other biolo-
gists, chemists, materials scientists, and biomedical engi-
neers, so that entirely new and diverse approaches might
be brought to bear on this important area.
Children's Hospital of Orange County (CHOC) just
received a one-of-a-kind federal award from the National
Institutes of Health (NIH). This award establishes CHOC
as having the first federally-funded training grant to incor-
porate new induced pluripotent stem cell derivation tech-
nology as part of its training curriculum. This curriculum
is a critical adjunct to the NIH's recent stem cell initiative
that will fund new research grants that propose to use this
new technology. Dr. Philip H. Schwartz, a Senior Scientist
in the Centers of Neuroscience and Translational Research
at the CHOC Research Institute and the principal investi-
gator of the grant, will teach this new technology which
allows the derivation of pluripotent stem cells from adult
cells, rather than from human embryos.
CHOC has been running 10-day, intensive, PSC culture
training courses since 2004, being one of the first in the
country and the first in the Western United States to con-
tinuously offer this comprehensive, specialized training.
These NIH-sponsored training courses provide hands-on
training for investigators and, by bringing together some
of the leading experts on PSC technology, train students in
the successful culture, maintenance, and manipulation of
ePSCs. In addition, the course directors have published
very well-received book, Human Stem Cell Culture – A
Laboratory Guide[7], that details all of the technologies
that the course covers, as well as other techniques relevant
to the field. With the additional NIH funding, students of
the next course can now be taught iPSC derivation, isola-
tion, and propagation, in addition to the now-standard
ePSC techniques. iPSCs will be derived from fibroblasts,
using existing methodologies, by transducing them with
lentiviral vectors encoding for the transcription factor
genes OCT4, NANOG, LIN28, and SOX2. Students will be
taught how to isolate and characterize iPSCs and will also
be taught proper techniques for banking PSCs. All of these
techniques will be taught using a temporal shift method-
ology such that students, at the very beginning of the
course, will be given cultures at all major stages, from
fibroblast, to very early re-programming, to establishment
of colonies, to expanding colonies, to colonies ready for
banking. The students will take these cultures and advance
each of them to the next stage and characterize them
appropriately. Thus, by the end of the 10-day course, the
students will have been well-exposed, in compressed tem-
poral sequence, to what takes many weeks to accomplish
in real practice and, thus, will possess the essential skill set
needed for properly deriving and characterizing iPSCs in
their own laboratories.
Dr. Schwartz' stem cell research laboratory at CHOC
focuses on the use of stem cells to understand the neuro-
biological causes of autism and other neurodevelopmen-
tal disorders such that new treatments may be discovered.
Preclinical trials using stem cell therapy in a model of a
lysosomal storage disease are also in progress in his labo-
ratory. Finally, the laboratory houses the National Human
Neural Stem Cell Resource http://www.nhnscr.org, a
repository of human stem cells that are made widely avail-
able to the scientific community. The on-line application
for the training course is found at this site. Dr. Schwartz
welcomes e-mail at pschwartz@choc.org.
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